Seminars in Arthritis and Rheumatism
Volume 37, Issue 3 , Pages 137-148 , December 2007

Schnitzler Syndrome: Beyond the Case Reports: Review and Follow-Up of 94 Patients with an Emphasis on Prognosis and Treatment

  • Heleen D. de Koning, MSc
  • ,
  • Evelien J. Bodar, MD
  • ,
  • Jos W.M. van der Meer, MD, PhD
  • ,
  • Anna Simon, MD, PhD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Anna Simon, MD, PhD, Division of General Internal Medicine, 484, Department of Internal Medicine, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands.
  • ,
  • Schnitzler Syndrome Study Group

References 

  1. Lipsker D, Veran Y, Grunenberger F, Cribier B, Heid E, Grosshans E. The Schnitzler syndrome: Four new cases and review of the literature. Medicine (Baltimore). 2001;80:37–44
  2. Schnitzler L. Lésions urticariennes chroniques permanentes (érythème pétaloïde?) Cas cliniques. No 46 B J Dermatol Angers. 1972;Abstract 46
  3. Akimoto R, Yoshida M, Matsuda R, Miyasaka K, Itoh M. Schnitzler’s syndrome with IgG kappa gammopathy. J Dermatol. 2002;29:735–738
  4. Altmeyer P, Welke S. Makroglobulinamie Waldenstrom assoziiert mit einem chronisch rezidivierenden urtikariellen Exanthem. Akt Dermatol. 1977;3:71–76
  5. Baleva M, Vulcheva T, Nikolova K. Vascularite urticarienne er macroglobulinémie (syndrome de Schnitzler) après une sinusite maxillaire sévère et une septicémie fongique: à propos d’une observation. Nouv Dermatol. 1995;14:53–54
  6. Barriere H, Schnitzler L, Moulin G, Grolleau Y. Lesions urticariennes chroniques et macroglobulinemie (A propos de cinq observations). Sem Hop. 1976;52:221–227
  7. Baty V, Hoen B, Hudziak H, Aghassian C, Jeandel C, Canton P. Schnitzler’s syndrome: two case reports and review of the literature. Mayo Clin Proc. 1995;70:570–572
  8. Berdy SS, Bloch KJ. Schnitzler’s syndrome: a broader clinical spectrum. J Allergy Clin Immunol. 1991;87:849–854
  9. Blaise S, Vallat JM, Tabaraud F, Bonnetblanc JM. Syndrome de Schnitzler associé à une forme sensitive pure de polyradiculonévrite inflammatoire démyélinisante chronique. Ann Dermatol Venereol. 2003;130:348–351
  10. Blasum , Wozel G, Patzak A, Julius UMM. Schnitzler’s syndrome (urticaria vasculitis and monoclonal gammopathie of IgM type): successful treatment with extracorporal immunoadsorption. Ann Dermatol Vénéréol. 1997;124(suppl):117
  11. Bonnetblanc JM, Drouet M, Laplaud P, Bedane C, Bernard P. Urticaria with macroglobulinaemia (Disease activity associated alterations in immunoglobulins profile and bone marrow hypodiploidy). Dermatologica. 1990;181:41–43
  12. Borradori L, Rybojad M, Puissant A, Dallot A, Verola O, Morel P. Urticarial vasculitis associated with a monoclonal IgM gammopathy: Schnitzler’s syndrome. Br J Dermatol. 1990;123:113–118
  13. Carlioz R, Haas C, Jaubert F, Allouche C, Lowenstein W, Le Jeunne C, et al. Maladie de Waldenstrom avec lymphome diffus a grandes cellules immunoblastiques et urticaire chronique. Ann Med Interne (Paris). 1989;140:51–52
  14. Cianchini G, Colonna L, Bergamo F, Angelo C, Puddu P. Efficacy of Psoralen-UV-A therapy in 3 cases of Schnitzler syndrome. Arch Dermatol. 2001;137:1536–1537
  15. Clauvel JP, Brouet JC, Danon F, Leibowitch M, Seligmann M. Chronic urticaria with monoclonal IgM - a report of five cases. Clin Immunol Immunopathol. 1982;25:348–353
  16. Cream JJ, Porter D. Urticaria in Waldenstrom’s macroglobulinaemia. J R Soc Med. 1979;72:858–859
  17. de Castro FR, Masouye I, Winkelmann RK, Saurat JH. Urticarial pathology in Schnitzler’s (hyper-IgM) syndrome. Dermatology. 1996;193:94–99
  18. de Kleijn EM, Telgt D, Laan R. Schnitzler’s syndrome presenting as fever of unknown origin (FUO) (The role of cytokines in its systemic features). Neth J Med. 1997;51:140–142
  19. de Koning HD, Bodar EJ, Simon A, van der Hilst JC, Netea MG, van der Meer JWM. Beneficial response to anakinra and thalidomide in Schnitzler’s syndrome. Ann Rheum Dis. 2006;65:542–544
  20. De Saint-Pierre V, Ehrhart A, Baron D, Plantin P, Le Goff P. Urticaire systemique osteopathie condensante gammapathie monoclonale (syndrome de Schnitzler): a propos d’un cas. Rev Rhum Mal Osteoartic. 1992;59:288–292
  21. de Waele S, Lecouvet FE, Malghem J, Jamar F, Lambert M. Schnitzler’s syndrome: an unusual cause of bone pain with suggestive imaging features. AJR Am J Roentgenol. 2000;175:1325–1357
  22. Doutre MS, Beylot C, Bioulac P, Bezian JH. Monoclonal IgM and chronic urticaria: two cases. Ann Allergy. 1987;58:413–414
  23. Dupuy O, Pinede L, Coppere B, Duhaut P, Pasquier J, Ninet J. Syndrome de Schnitzler d’evolution stable sur une periode de 18 ans: Une observation. Presse Med. 1995;24:1402
  24. Famularo G, Barracchini A, Minisola G. Severe thrombophilia with antiphospholipid syndrome and hyperhomocysteinemia in a patient with Schnitzler’s syndrome. Clin Exp Rheumatol. 2003;21:366–368
  25. Fermand J-P. An additional example of the diversity of the manifestations associated with macroglobulinemia: the Schnitzler Syndrome. Third International Workshop on Waldenström’s Macroglobulinemia. Paris 2004;
  26. Ferrando F, Pujol J, Hortells JL, Navarro M, Pinol J, Carapeto F. Schnitzler’s syndrome: report of a case with bone osteolysis. J Investig Allergol Clin Immunol. 1994;4:203–205
  27. Gallo R, Sabroe RA, Black AK, Greaves MW. Schnitzler’s syndrome: no evidence for autoimmune basis in two patients. Clin Exp Dermatol. 2000;25:281–284
  28. Germain P, Fach J, Bui N, Traissac T, Delbrel X, Le Bras M, et al. Syndrome de Schnitzler: une cause rare d’urticaire systemique. Rev Med Interne. 2000;21:285–289
  29. Glemarec J, Guillot P, Varin S, Muller F, Berthelot JM, Maugars Y. Syndrome de Schnitzler: un nouveau cas avec gammapathie monoclonale IgG (17ème congrès de Rhumatologie Société française de Rhumatologie Abstract). 2003;
  30. Gossrau G, Pfeiffer C, Meurer M, Reichmann H, Lampe JB. Schnitzler’s syndrome with neurological findings. J Neurol. 2003;250:1248–1250
  31. Goupille P, Pizzuti P, Diot E, Jattiot F, Guilmot JL, Valat JP. Schnitzler’s syndrome (urticaria and macroglobulinemia) dramatically improved with corticosteroids. Clin Exp Rheumatol. 1995;13:95–98
  32. Govindaraju S, Brochot P, Ringot AC, Paternotte L, Morrone A, Eschard JP, et al. Urticaire chronique-macroglobulinemie (syndrome de Schnitzler): evolution vers un myelome a IgM (A propos d’un cas). Rev Med Interne. 1993;14:780–783
  33. Janier M, Bonvalet D, Blanc MF, Lemarchand F, Cavelier B, Ribrioux A, et al. Chronic urticaria and macroglobulinemia (Schnitzler’s syndrome): report of two cases. J Am Acad Dermatol. 1989;20:206–211
  34. Kropp J-D, Czarnetzki BM. Urticaria—Vasculitis und Schnitzler-Syndrom. Allergologie. 1994;17:S17–S20
  35. Kuenzli S, Buchet S, Saurat JH. Successful treatment of Schnitzler’s syndrome with interferon alfa-2b. Dermatology. 2002;205:74
  36. Lambert D, Legoux A, Chapuis JL, Benoit JP, Putelat R. Urticaire chronique et macroglobulinemie. Nouv Presse Med. 1982;11:1948
  37. Lautenschlager S, Itin PH. Das Schnitzler Syndrom. Hautarzt. 1993;44:781–784
  38. Lauwers A, Chouvy V, Mosnier JF, Misery L, Alexandre C. A case of Schnitzler’s syndrome with nodular regenerative hyperplasia of the liver. Rev Rhum Engl. 1999;66:281–283
  39. Lebbe C, Rybojad M, Klein F, Oksenhendler E, Catala M, Danon F, et al. Schnitzler’s syndrome associated with sensorimotor neuropathy. J Am Acad Dermatol. 1994;30:316–318
  40. Lecompte M, Blais G, Bisson G, Maynard B. Schnitzler’s syndrome. Skeletal Radiol. 1998;27:294–296
  41. Lim W, Shumak KH, Reis M, Perez-Ordonez B, Sauder D, Fam A, et al. Malignant evolution of Schnitzler’s syndrome—chronic urticaria and IgM monoclonal gammopathy: report of a new case and review of the literature. Leuk Lymphoma. 2002;43:181–186
  42. Lin RY, Jagannath S. Treatment of Schnitzler’s syndrome with colchicine: a case report. Internet J Asthma. 2005;4:
  43. Lozano GF, Aguirre PA, Rivera Civico JM, Nevado SM. The Schnitzler syndromeA case report. Med Clin (Barc). 1999;112:158–159
  44. Machet L, Vaillant L, Machet MC, Esteve E, De Muret A, Khallouf R, et al. Schnitzler’s syndrome (urticaria and macroglobulinemia) associated with pseudoxanthoma elasticum. Acta Derm Venereol. 1992;72:22–24
  45. Martinez-Taboada VM, Fontalba A, Blanco R, Fernandez-Luna JL. Successful treatment of refractory Schnitzler syndrome with anakinra: comment on the article by Hawkins et al. Arthritis Rheum. 2005;52:2226–2227
  46. Maynard B. Schnitzler’s syndrome: evolution towards systemic amyloidosis. 80th Canadian Dermatology Association Annual Conference; 2005;Abstract
  47. Modiano P, Barbaud A, Laveine ECS, Weber M, Schmutz JL. Efficacité de la PUVA thérapie dans un syndrome de Schnitzler. Nouv Dermatol. 1995;14:362–363
  48. Morita A, Sakakibara S, Yokota M, Tsuji T. A case of urticarial vasculitis associated with macroglobulinemia (Schnitzler’s syndrome). J Dermatol. 1995;22:32–35
  49. Nashan D, Sunderkotter C, Bonsmann G, Luger T, Goerdt S. Chronic urticaria, arthralgia, raised erythrocyte sedimentation rate and IgG paraproteinaemia: a variant of Schnitzler’s syndrome?. Br J Dermatol. 1995;133:132–134
  50. Oborilova A, Adam Z. Schnitzler’s syndrome. Vnitr Lek. 1998;44:423–427
  51. Olsen E, Forre O, Lea T, Langeland T. Unique antigenic determinants (idiotypes) used as markers in a patient with macroglobulinemia and urticariaSimilar idiotypes demonstrated in the skin and on peripheral blood lymphocytes. Acta Med Scand. 1980;207:379–384
  52. Pacchiano G, Di Benedetto A, Palladini G, Merlini G. Schnitzler syndrome: caso clinico raro. V Congresso interregionale Societa Italiana di Nefrologia. 2004;Abstract
  53. Pascual-Lopez M, Hernandez-Nunez A, Sanchez-Perez J, Fernandez-Herrera J, Garcia-Diez A. Schnitzler’s syndrome with monoclonal IgG kappa gammopathy: good response to cyclosporin. J Eur Acad Dermatol Venereol. 2002;16:267–270
  54. Paulin P, Cusset C, Jacquelin L, Pages JM, Chapalain JC. Syndrome de Schnitzler: Une nouvelle observation. Presse Med. 1992;21:1758–1761
  55. Peronato G, De Sandre P, Bonoldi E. Urticaria osteocondensation and monoclonal gammopathy (Schnitzler syndrome): a new case report. On-line Archives of Rheumatology. 1999;34:
  56. Peterlana D, Puccetti A, Tinazzi E, Simeoni S, Lunardi C. Schnitzler’s syndrome treated successfully with intravenous pulse cyclophosphamide. Scand J Rheumatol. 2005;34:328–330
  57. Puddu P, Cianchini G, Girardelli CR, Colonna L, Gatti S, de Pita O. Schnitzler’s syndrome: report of a new case and a review of the literature. Clin Exp Rheumatol. 1997;15:91–95
  58. Pujol RM, Barnadas MA, Brunet S, de Moragas JM. Urticarial dermatosis associated with Waldenstrom’s macroglobulinemia. J Am Acad Dermatol. 1989;20:855–857
  59. Rybojad M, Moraillon I, Cordoliani F, Lebbe C, Baccard M, Flageul B, et al. Syndrome de Schnitzler avec deficit genetique en C4: Deux observations. Ann Dermatol Venereol. 1993;120:783–785
  60. Sanchez G, Ano M, Garcia-Aviles C, Dieguez I. Schnitzler syndrome: a case study. J Investig Allergol Clin Immunol. 2000;10:41–43
  61. Sanmartin O, Febrer I, Botella R, Grau M, de la Cuadra J, Aliaga A. Urticarial lesions and monoclonal IgM gammopathy (Schnitzler’s syndrome). Arch Dermatol. 1994;130:1195–1198
  62. Schartz NE, Buder S, Sperl H, Audring H, Paus R, Tebbe B, et al. Report of a case of Schnitzler’s syndrome treated successfully with interferon alpha 2b. Dermatology. 2002;205:54–56
  63. Schnitzler L, Hurez D, Verret JL. Urticaire chronique-osteocodensation-macroglobulinemie (Cas princeps. Etude sur 20 ans). Ann Dermatol Venereol. 1989;116:547–550
  64. Shibolet O, Schatz O, Krieger M, Maly A, Caraco Y. Schnitzler syndrome: chronic urticaria, fever and immunoglobulin M monoclonal gammopathy. Isr Med Assoc J. 2002;4:466–467
  65. Sperr WR, Natter S, Baghestanian M, Smolen J, Wolff K, Binder BR, et al. Autoantibody reactivity in a case of Schnitzler’s syndrome: evidence for a Th1-like response and detection of IgG2 anti-FcepsilonRIalpha antibodies. Int Arch Allergy Immunol. 2000;122:279–286
  66. Tomkova H, Shirafuji Y, Arata J. Schnitzler’s syndrome versus adult onset Still’s disease. Eur J Dermatol. 1998;8:118–121
  67. Welsh B, Tate B. Schnitzler’s syndrome: report of a case with progression to Waldenstrom’s macroglobulinaemia. Australas J Dermatol. 1999;40:201–203
  68. Wilhelmi ML, Ocana Wilhelmi J, Ocana Sierra J. Schnitzler’s syndrome and pseudoxanthoma elasticum. 3rd Congress of EADV Copenhagen. 1993;20:159;Abstract FC
  69. Winckelmann G, Nagel HG, Maier R, Reuther G. Schnitzler-Syndrom als Ursache eines rezidivierenden Fiebers unbekannter Ursache. Dtsch Med Wochenschr. 1996;121:860–864
  70. Worm M, Kolde G. Schnitzler’s syndrome: successful treatment of two patients using thalidomide. Br J Dermatol. 2003;148:601–602
  71. Dalle S, Balme B, Sebban C, Pariset C, Berger F, Thomas L. Schnitzler syndrome associated with systemic marginal zone B-cell lymphoma. Br J Dermatol. 2006;155(4):827–829
  72. Singh B, Ezziddin S, Rabe E, Biersack HJ, Ahmadzadehfar H. Bone scan appearance supportive of Schnitzler’s syndrome: report of two new cases. Clin Nucl Med. 2006;31(3):151–153
  73. Lipsker D, Spehner D, Drillien R, Schmitt P, Cribier B, Heid E, et al. Schnitzler syndrome: heterogeneous immunopathological findings involving IgM-skin interactions. Br J Dermatol. 2000;142:954–959
  74. Saurat JH, Schifferli J, Steiger G, Dayer JM, Didierjean L. Anti-interleukin-1 alpha autoantibodies in humans: characterization, isotype distribution and receptor-binding inhibition-higher frequency in Schnitzler’s syndrome (urticaria and macroglobulinemia). J Allergy Clin Immunol. 1991;88:244–256
  75. Dinarello CA. Blocking IL-1 in systemic inflammation. J Exp Med. 2005;201:1355–1359
  76. Nakamura I, Jimi E. Regulation of osteoclast differentiation and function by interleukin-1. Vitam Horm 2006. 2006;74:357–370
  77. Kaplan AP. Clinical practice: chronic urticaria and angioedema. N Engl J Med. 2002;346:175–179
  78. Karakiledes M, Monson KL, Volcheck GW, Weiler CR. Monoclonal gammopathies and malignancies in patients with chronic urticaria. Int J Dermatol. 2006;45:1032–1038
  79. Lombardi R, Erne B, Lauria G, Pareyson D, Borgna M, Morbin M, et al. IgM deposits on skin nerves in anti-myelin-associated glycoprotein neuropathy. Ann Neurol. 2005;57:180–187
  80. Kyle RA, Rajkumar SV. Monoclonal gammopathies of undetermined significance: a review. Immunol Rev. 2003;194:112–139
  81. Kozel MM, Sabroe RA. Chronic urticaria: aetiology, management and current and future treatment options. Drugs. 2004;64:2515–2536
  82. Zuberbier T, Bindslev-Jensen C, Canonica W, Grattan CE, Greaves MW, Henz BM, et al. EAACI/GALEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy. 2006;61:316–320
  83. Almerigogna F, Giudizi MG, Cappelli F, Romagnani S. Schnitzler’s syndrome: what’s new?. J Eur Acad Dermatol Venereol. 2002;16:214–219
  84. Simon A, van der Meer JWM, Drenth JPH. Familial auto-inflammatory syndromes (Chapter 112). In:  Harris ED,  Budd RC,  Firestein GS editor. Kelley’s Textbook of Rheumatology. 7th ed.. Philadelphia: Saunders; 2004;p. 1773–1788
  85. Hawkins PN, Lachmann HJ, Aganna E, McDermott MF. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum. 2004;50:607–612
  86. Drenth JP, van der Meer JWM. Hereditary periodic fever. N Engl J Med. 2001;345:1748–1757
  87. Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR, et al. POEMS syndrome: definitions and long-term outcome. Blood. 2003;101:2496–2506
  88. Dimopoulos MA, Anagnostopoulos A. Waldenstrom’s macroglobulinemia. Best Pract Res Clin Haematol. 2005;18:747–765
  89. Lipsker D. The Schnitzler syndrome—a treatment at last?. Dermatology. 2002;205:1–2
  90. Machet L, Vaillant L, Machet MC, Reisenleiter M, Goupille P, Lorette G. Schnitzler’s syndrome (urticaria and macroglobulinemia): evolution to Waldenstrom’s disease is not uncommon. Acta Derm Venereol. 1996;76:413
  91. Verret JL, Leclech C, Rousselet MC, Hurez D, Schnitzler L. Syndrome de Schnitzler et maladie de Waldenstrom (Evolution terminale du cas princeps). Ann Dermatol Venereol. 1993;120:459–460
  92. Kyle RA, Therneau TM, Rajkumar SV, Remstein ED, Offord JR, Larson DR, et al. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood. 2003;102:3759–3764
  93. Soubrier M, Dubost JJ, Jouanel P, Tridon A, Flori B, Leguille C, et al. Multiples complications d’une IgM monoclonale. Rev Med Interne. 1994;15:484–486
  94. Husak R, Nestoris S, Goerdt S, Orfanos CE. Severe course of chronic urticaria. Br J Dermatol. 2000;142:581–582
  95. Varella TC, Nishimura MY, Machado MC, de Moraes-Vasconcelos D, Rivitti EA. Schnitzler’s syndrome without monoclonal gammopathy. Acta Derm Venereol. 2005;85:272–273
  96. Treon SP, Hunter ZR, Aggarwal A, Ewen EP, Masota S, Lee C, et al. Characterization of familial Waldenstrom’s macroglobulinemia. Ann Oncol. 2006;17:488–494
  97. Hawkins PN, Bybee A, Aganna E, McDermott MF. Response to anakinra in a de novo case of neonatal-onset multisystem inflammatory disease. Arthritis Rheum. 2004;50:2708–2709
  98. Hoffman HM, Rosengren S, Boyle DL, Cho JY, Nayar J, Mueller JL, et al. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet. 2004;364:1779–1785
  99. Simon A, Bodar EJ, van der Hilst JC, van der Meer JWM, Fiselier TJ, Cuppen MP, et al. Beneficial response to interleukin 1 receptor antagonist in TRAPS. Am J Med. 2004;117:208–210
  100. McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor (TNFR1) define a family of dominantly inherited autoinflammatory syndromes. Cell. 1999;97:133–144

 H.D.K. is supported by a grant from Studiefonds Ketel 1; A.S. is supported by a ZonMW Veni grant.

PII: S0049-0172(07)00073-X

doi: 10.1016/j.semarthrit.2007.04.001

Seminars in Arthritis and Rheumatism
Volume 37, Issue 3 , Pages 137-148 , December 2007